ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,830Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 1187

$573K Total Retail Price of All Prescriptions

Rank: 138 out of 1187

575 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,024 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 365 334 1 3
FUROSEMIDE 316 294 2 8
AMLODIPINE BESYLATE 309 295 3 2
OMEPRAZOLE 309 297 3 5
WARFARIN SODIUM 299 283 5 13
SIMVASTATIN 285 262 6 1
METOPROLOL TARTRATE 272 266 7 10
METOPROLOL SUCCINATE 254 229 8 11
DONEPEZIL HCL 239 239 9 26
SERTRALINE HCL 193 193 10 22
LISINOPRIL 192 191 11 4
NAMENDA 181 181 12 44
FAMOTIDINE 172 168 13 48
DIOVAN 171 164 14 17
GABAPENTIN 159 146 15 23
DIGOXIN 154 154 16 65
MIRTAZAPINE 149 146 17 54
ESCITALOPRAM OXALATE 142 130 18 51
RISPERIDONE 134 134 19 58
OXYCODONE-ACETAMINOPHEN 131 98 S2 20 47
TAMSULOSIN HCL 123 119 21 29
PANTOPRAZOLE SODIUM 120 97 22 42
POTASSIUM CHLORIDE 116 116 23 32
SPIRONOLACTONE 116 106 23 98
DIVALPROEX SODIUM 113 112 25 79
ATORVASTATIN CALCIUM 109 98 26 6
ALLOPURINOL 97 85 27 50
METFORMIN HCL 93 74 28 7
NYSTATIN 93 87 28 123
TRAMADOL HCL 90 90 30 28
ENALAPRIL MALEATE 89 69 31 27
PREDNISONE 86 85 32 61
CITALOPRAM HBR 84 70 33 45
SANTYL 83 65 34 150
LATANOPROST 80 80 35 243
FENTANYL 79 66 S2 36 82
CARBIDOPA-LEVODOPA 73 73 37 99
CLOPIDOGREL 72 72 38 33
DIOVAN HCT 71 56 39 40
LANTUS 67 50 40 77
LIDODERM 67 67 40 80
FLUTICASONE PROPIONATE 66 51 42 31
PERMETHRIN 65 65 43 226
HYDROCHLOROTHIAZIDE 62 62 44 9
LACTULOSE 62 43 44 96
RESTASIS 61 61 46 313
DILTIAZEM 24HR CD 59 59 47 131
LOSARTAN POTASSIUM 58 57 48 21
GLIMEPIRIDE 54 45 49 30
OXYCODONE HCL 54 53 S2 49 38
ISOSORBIDE MONONITRATE ER 54 54 49 66
FINASTERIDE 53 53 52 110
ATENOLOL 53 49 52 18
MELOXICAM 51 51 54 49
NITROGLYCERIN PATCH 51 51 54 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.